McCutcheon

Power Leaves Corp. Expands Canadian Market Presence with Coca Essence Supply Agreement

Retrieved on: 
Tuesday, November 7, 2023

TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Power Leaves Corp. (“PLC”), a manufacturer of decocainized coca leaf essence, announced that it has signed a supply agreement with a Canadian food and beverage manufacturer (the “Customer”). Under the agreement, the Customer has a committed purchase obligation of 4,500 litres of PLC’s coca essence product at $100 per litre in 2024, increasing to 9,000L in 2025, for a total contract value of $1.35M. 

Key Points: 
  • TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Power Leaves Corp. (“PLC”), a manufacturer of decocainized coca leaf essence, announced that it has signed a supply agreement with a Canadian food and beverage manufacturer (the “Customer”).
  • “We're thrilled to announce the signing of our first large-commercial contract for our novel coca essence product.
  • The minimum purchasing obligations under the agreement are expected to be a significant driver of PLC's Coca Essence revenue for the Canadian market.
  • While Coca-Cola continues to leverage coca extract in its namesake ingredient, PLC has a robust product development pipeline of novel coca products that have previously been unavailable to the market, including our coca essence product.

Nine Mile Metals to Drill the Wedge Project, Bathurst Mining Camp, New Brunswick

Retrieved on: 
Thursday, October 26, 2023

Lantech Drilling has been engaged to drill these high priority targets once it completes the current hole at Nine Mile Brook.

Key Points: 
  • Lantech Drilling has been engaged to drill these high priority targets once it completes the current hole at Nine Mile Brook.
  • In addition to the historic Wedge Mine, the Cominco Wedge Mine Extension (never drill tested), the newly acquired Wedge North Target, which completes the California Lake East Trend, West Wedge and Tribag (representing a 4.5kms VMS Trend) and Lower 44 Mile Brook targets.
  • Figure 1: “New” Drill Program High Priority Targets, Wedge Project Area, New Brunswick
    Discovered in 1956, the Wedge Mine is located at the northern terminus of a strong magnetic linear (Figure 1).
  • To the northwest, both the West Wedge and Tribag lie along the west flank of a similar magnetic anomaly near parallel to the one at the Wedge.

Positive results from first-in-human completely leadless CRT in the US, published in The Journal of the American College of Cardiology

Retrieved on: 
Wednesday, October 25, 2023

The positive results published in JACC are based on a 1-year follow-up of the first-in-human implantation in the US of totally leadless CRT pacing utilizing the Micra™ leadless pacing system in the right ventricle in conjunction with EBR's investigational WiSE® CRT Electrode in the left ventricle of the heart.

Key Points: 
  • The positive results published in JACC are based on a 1-year follow-up of the first-in-human implantation in the US of totally leadless CRT pacing utilizing the Micra™ leadless pacing system in the right ventricle in conjunction with EBR's investigational WiSE® CRT Electrode in the left ventricle of the heart.
  • This first use in the US of the WiSE CRT System as a first-line therapy is a future market expansion opportunity for EBR.
  • "It's great to see these positive results being published in a world-leading cardiology journal, such as The Journal of the American College of Cardiology," said John McCutcheon, President & CEO of EBR Systems.
  • "This case study highlights the potential of totally leadless CRT for patients struggling with traditional CRT, but also beyond these patient groups, the 64 million heart failure patients across the globe."

InfoBionic Receives FDA 510(k) Clearance for its Next Generation MoMe® ARC Solution

Retrieved on: 
Tuesday, October 10, 2023

CHELMSFORD, Mass. , Oct. 10, 2023 /PRNewswire-PRWeb/ -- InfoBionic, Inc. today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MoMe®‥ARC, their 3rd Generation remote ECG monitoring device paired with their inaugural Bluetooth diagnostic 6-lead sensor designed to aid physicians in their diagnosis of cardiac arrhythmias in patients with a demonstrated need for cardiac monitoring. "We're thrilled to announce FDA 510(k) clearance to market the MoMe®‥ARC solution, which supports our mission to create superior patient monitoring solutions for arrhythmia detection and virtual care and chronic disease management," said‥Dave MacCutcheon, Regulatory and Chief Operating Officer at InfoBionic.

Key Points: 
  • "We're thrilled to announce FDA 510(k) clearance to market the MoMe®‥ARC solution, which supports our mission to create superior patient monitoring solutions for arrhythmia detection and virtual care and chronic disease management," said‥Dave MacCutcheon, Regulatory and Chief Operating Officer at InfoBionic.
  • In addition, MoMe® ARC leverages a comprehensive cloud-based proprietary platform to deliver on-demand, actionable data and analytics directly to the clinicians.
  • This next generation device builds on the market success of innovative MoMe® Kardia II by providing a decoupled 2-channel – 6-Lead Sensor.
  • InfoBionic expects to begin shipping the new generation MoMe®‥ARC Device in Q4 2023.

Power Leaves Corp. Signs Agreement With the Colombian Agricultural Research Corporation; Announces July Investor Webinar

Retrieved on: 
Monday, June 26, 2023

TORONTO, Ontario, June 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Power Leaves Corp. (“PLC”), a manufacturer of decocainized coca leaf extract, announced that it has signed an agreement with the Colombian Agricultural Research Corporation (“Agrosavia”) and the NASA WALA Foundation (“NASA”).

Key Points: 
  • PLC will also be holding a webinar on July 6th at 4:30 pm ET to discuss ongoing commercialization efforts.
  • TORONTO, Ontario, June 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Power Leaves Corp. (“PLC”), a manufacturer of decocainized coca leaf extract, announced that it has signed an agreement with the Colombian Agricultural Research Corporation (“Agrosavia”) and the NASA WALA Foundation (“NASA”).
  • Specifically, through this agreement, we will jointly develop additional uses and formulations for PLC’s fertilizer additives to support the agricultural industry in Colombia.
  • This agreement with Agrosavia, the leading representative entity for the Colombian Government in the agricultural industry, gives PLC greater proximity and credibility within Colombia.

Splitit strengthens board with appointments of Dan Charron and Nandan Sheth while adding key hires to the executive team

Retrieved on: 
Monday, July 18, 2022

Splitit CEO Nandan Sheth, who joined the company in March 2022, will become managing director.

Key Points: 
  • Splitit CEO Nandan Sheth, who joined the company in March 2022, will become managing director.
  • The company also announces three senior hires to the executive team, including Chief Revenue Officer, Head of Product and Head of Operations.
  • Payments industry veteran Dan Charron joins the board as Independent Non-Executive Director, and CEO Nandan Sheth joins as the Managing Director.
  • "We are delighted to have Dan and Nandan join the Board," Splitit Chair Dawn Robertson said.

Nation's Veterans Get New Cardiac Monitoring/Diagnosis Services as VHA Awards Contract to InfoBionic on GSA Advantage Program

Retrieved on: 
Tuesday, November 2, 2021

The VHA provides care to the nation's military veterans at 1,293 healthcare facilities, which includes 171 Veterans Affairs medical centers and 1,112 out-patient sites.

Key Points: 
  • The VHA provides care to the nation's military veterans at 1,293 healthcare facilities, which includes 171 Veterans Affairs medical centers and 1,112 out-patient sites.
  • There are currently more than 9 million veterans enrolled in the VHA healthcare system.
  • InfoBionic products are available to all federal buyers through the GSA Advantage program under contract 36F797721D0248.
  • Frost & Sullivan bestowed the 2019 North American Remote Cardiac Monitoring Technology Leadership Award upon InfoBionic.

Pat McCutcheon joins Harvard MedTech, A Digital Health Company, as Senior Vice President of Market Partnerships

Retrieved on: 
Monday, January 25, 2021

LAS VEGAS, Jan. 25, 2021 /PRNewswire/ -- Harvard MedTech, a digital health company, is pleased to announce that Pat McCutcheon has been named as Senior Vice President of Market Partnerships.

Key Points: 
  • LAS VEGAS, Jan. 25, 2021 /PRNewswire/ -- Harvard MedTech, a digital health company, is pleased to announce that Pat McCutcheon has been named as Senior Vice President of Market Partnerships.
  • Ms. McCutcheon has over 28 years of senior leadership and management experience in Worker's Compensation (WC).
  • Over the years, she has been a part of senior leadership teams with top industry innovators such as Optum (formerly PMSI), MedFocus and One Call.
  • Pat McCutcheon further explained, "Harvard MedTech's Vx Pain Relief Program is the right product at the right time for this industry.

REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors

Retrieved on: 
Wednesday, May 6, 2020

Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (MediPharm) (TSX: LABS).

Key Points: 
  • Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (MediPharm) (TSX: LABS).
  • We are tremendously pleased to have Pat join the Champignon Board, commented Gareth Birdsall, director of Champignon.
  • I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada, stated Pat McCutcheon.
  • Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified.

Champignon Appoints Pat McCutcheon to Board of Directors

Retrieved on: 
Wednesday, May 6, 2020

Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (MediPharm) (TSX: LABS).

Key Points: 
  • Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (MediPharm) (TSX: LABS).
  • We are tremendously pleased to have Pat join the Champignon Board, commented Gareth Birdsall, director of Champignon.
  • I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada, stated Pat McCutcheon.
  • Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified.